Company: APXIF
Filing Date: 2025-07-03
Form Type: F-4/A
Source: 0001213900-25-061545
Chunk: 142

Company: APx Acquisition Corp. I
Filing Date: 2025-07-03
Form: F-4/A
Chunk 142
---
 strategies have had and may continue to have a significant impact on our revenue. Periodically, we offer discounted prices and promotions for our Rewell offering to attract customers, including strategic partners. However, such offers and discounts may reduce our revenue and margins. Additionally, if our competitors engage in aggressive pricing strategies or other competitive activities, or if our own pricing strategies, which may evolve over time, fail to meet the price expectations of our customers and strategic partners or fail to increase margins, it could materially and adversely affect our business, financial condition, results of operations, and growth prospects. If we are unable to attract and retain high quality healthcare providers for our patients, our business, financial condition, and results of operations may be materially and adversely affected. Our success is dependent upon our continued ability to maintain a network of qualified telehealth providers. If we are unable to recruit and retain scientists, board -certifiedphysicians, and other healthcare professionals, it would adversely affect our business, financial condition, and results of operations and ability to grow. In any particular market, providers could demand higher payments or take other actions that could result in higher medical costs, less attractive service for our patients, or difficulty meeting regulatory or accreditation requirements. The failure to maintain or to 47 secure new cost -effectiveprovider contracts may result in a loss of or inability to grow our membership base, higher costs, less attractive service for our patients, and/or difficulty in meeting regulatory or accreditation requirements, any of which could have a material adverse effect on our business, financial condition, results of operations or growth prospects. Our results of operations can be adversely affected by labor shortages, turnover, and labor cost increases. Labor is a significant component of operating our business. A number of factors may adversely affect the labor force available to us or increase labor costs, including high employment levels, federal unemployment subsidies, increased wages offered by other employers, vaccine mandates and other government regulations and our responses thereto. As more employers offer remote work, we may have more difficulty recruiting for jobs that require on -siteattendance, such as certain clinical laboratory and sales roles. Although we have not experienced any material labor shortage to date, we have observed an overall tightening and increasingly competitive labor market. A sustained labor shortage or increased turnover rates within our employee base could lead to increased costs, such as increased overtime or financial incentives to meet demand and increased wage rates to attract and retain employees, and could negatively affect our ability to efficiently operate our clinical laboratories and overall business. If we are unable to hire and retain employees capable of